Search for: "Well Go USA, Inc." Results 41 - 60 of 713
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jan 2011, 9:06 am by Rebecca Tushnet
Organic Juice USA, Inc., 2011 WL 70562 (S.D.N.Y.) [read post]
22 Mar 2007, 5:34 am
Credit Suisse First Boston (USA), Inc., 2007 WL 816518 (5th Cir. [read post]
17 Feb 2010, 2:29 pm by Justin E. Gray
Timex Group USA, Inc., No. 3:10-cv-00286 (N.D. [read post]
25 Feb 2007, 8:53 pm
MasterCard Inc. has had such written agreements for years and Visa USA Inc. began incorporating a similar policy late last year. [read post]
24 Jul 2018, 8:32 am by Steven Cohen
Home Depot USA, Inc. et al – United States District Court – Central District of California – July 20th. 2018) involves a claim of strict product liability and negligence against the defendants related to a fire that broke out in the plaintiff’s garage. [read post]
27 Feb 2015, 8:09 am by Joe Consumer
Reynolds Tobacco Co., Philip Morris USA Inc. and Lorillard Tobacco Co. [read post]
20 Oct 2009, 10:06 pm
Steve Feingold took some heat when his client, Chippendales USA, Inc., recently sought to register its "Cuffs & Collar" costume mark on the basis of inherent distinctiveness. [read post]
12 Jul 2014, 5:42 pm by INFORRM
One can’t expect Greeks, Swedes and Italians to seek redress via the Irish Courts for the same reason why you can’t expect UK citizens to go the USA to take action against Google. [read post]
12 Jun 2017, 4:29 am by Edith Roberts
Tyrrell and Impression Products, Inc. v. [read post]
23 Apr 2008, 10:53 am
  In Cashcall, the Trial Court applied Pioneer Electronics (USA), Inc. v. [read post]
25 May 2020, 5:17 pm by Peter Mahler
The Company The above-described scenario played out in a lawsuit captioned Magarik v Kraus USA, Inc. [read post]
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]